Upcoming Investments

It was a week of lows — and some highs — in Bay Area housing news as the region posted small growth rates for property values and home sales. For the fiscal year ended June 30, San Francisco’s assessment roll for land, structures and business property that are subject to property tax increased 1.8 percent, or about $353.5 billion, the San Francisco Chronicle reported. That marks the lowest year-over-year growth rate since 2011 and a decrease from 2.2 percent expansion the year prior, putting the city in last of the Bay...

Institutional investors including Armistice Capital, RTW Investments, and Wellington Management have increased their exposure to rare disease therapeutics companies as the orphan drugs market sustains strong growth momentum. Multiple specialized healthcare funds and broad-market asset managers allocated significant capital to the sector in 2024 and continue to do so in 2025, driven by accelerated FDA approvals and collaboration deals demonstrating commercial potential for treatments targeting small patient populations. The global rare disease treatment market value reached $224.30 billion in 2024, with some analysts projecting growth to $527 billion by 2034, a...